Achieve Life Sciences (ACHV)
(Delayed Data from NSDQ)
$5.02 USD
-0.01 (-0.20%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $5.04 +0.02 (0.40%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.26 |
EPS Last Quarter | -0.25 |
Last EPS Surprise | -13.64% |
ABR | 1.00 |
Earnings ESP
|
-3.85% |
---|---|
Current Year | -1.03 |
Next Year | -1.11 |
EPS (TTM) | -1.11 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.26 | -0.28 | -1.03 | -1.11 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.27 | -0.30 | -1.07 | -1.15 |
High Estimate | -0.22 | -0.20 | -0.89 | -0.93 |
Low Estimate | -0.29 | -0.33 | -1.13 | -1.24 |
Year ago EPS | -0.34 | -0.26 | -1.50 | -1.03 |
Year over Year Growth Est. | 23.53% | -7.69% | 31.33% | -7.45% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 2 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.26 | -0.28 | -1.03 | -1.11 |
7 Days Ago | -0.26 | -0.28 | -1.03 | -1.11 |
30 Days Ago | -0.26 | -0.27 | -1.01 | -1.09 |
60 Days Ago | -0.25 | -0.27 | -1.05 | -1.00 |
90 Days Ago | -0.25 | -0.27 | -1.04 | -0.99 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.27 | -0.30 | -1.07 | -1.15 |
Zacks Consensus Estimate | -0.26 | -0.28 | -1.03 | -1.11 |
Earnings ESP | -3.85% | -8.43% | -3.88% | -3.91% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.25 | -0.26 | -0.26 | -0.34 | NA |
Estimate | -0.22 | -0.24 | -0.32 | -0.34 | NA |
Difference | -0.03 | -0.02 | 0.06 | 0.00 | 0.00 |
Surprise | -13.64% | -8.33% | 18.75% | 0.00% | -0.81% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more